Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

health and fitness

Youfit Health Clubs Reopens Clubs in AL, LA, VA and Nationwide

Leave a comment


News Image


DEERFIELD BEACH, Fla. (PRWEB)

After temporarily closing all locations in March due to the coronavirus pandemic, Youfit Health Clubs has begun gradually reopening its doors as the country moves into the next phases of easing coronavirus restrictions. Youfit has already reopened 20 clubs across four states, and yesterday reopened its first location in Alabama: Huntsville – Bailey Cove Rd., its first in Louisiana: Harvey – Manhattan Blvd., and its first in Virginia: Richmond – Hull Street Rd.

In addition, the following Youfit Health Clubs in Arizona, Florida, and Texas reopened this week, bring the total number of open clubs to 39:

Youfit has committed to meeting all applicable guidelines, including those mandated by the government and implementing safety precautions including the following:

  • Each and every Youfit Health Clubs location has undergone a deep clean that includes the disinfecting and maintenance of all equipment, surfaces, and facilities.

  • The clubs are incorporating new social distancing plans to keep staff and members safe. This includes creating greater distance between machines and the implementation of no contact check-in and membership enrollment processes.

  • There will be stringent regular sanitizing and disinfecting protocols.

  • Lockers and showers at each location will be closed temporarily. YouGX Group Fitness classes will resume at a later date.

  • A new membership code of conduct will be implemented.

  • The Youfit team is being fully trained on these new policies and procedures and is committed to making the return as smooth as possible.

Members will receive further communication on the reopening of their specific club through email and text if they have opted in. Additional information will be available on the Youfit website, social media channels and at each club.

About Youfit

Youfit Health Clubs is a gym that’s about one thing only: You. Founded in 2008, Youfit offers affordable gym memberships at state-of-the-art facilities to help members get the most out of life.

Share article on social media or email:

Industry: Healthcare

Genetic Medicine will be the Solution to COVID-19, and Ligandal is Leading the way

Leave a comment


Andre Watson

Ligandal’s peptide is an exciting leap forward in our ability to address and neutralise the virus directly.


SAN FRANCISCO (PRWEB)

Vaccines currently in development face the dual challenge of overcoming the temporary immunity presented by coronavirus infection, and the SARS-CoV-2 virus’s highly effective cloaking mechanism that effectively renders it invisible to the immune system.

Ligandal’s technology has been designed around the unique genetic signature of the virus, which has informed the development of a peptide nanoscaffold. This peptide prevents the virus from binding with human cells, halting infection. The peptide also simultaneously disables the viral cloaking mechanism, making the virus vulnerable to an immune response.

Andre Watson, CEO and Founder of Ligandal, says, “I started Ligandal to create practical genetic medicine technology that solves the world’s most pressing health problems. We had been developing a way of training T-cells to attack cancer tumours, but when the COVID-19 pandemic began, I realised our technology would be effective at neutralising this single, virulent pathogen without requiring a gene therapy component. The beauty of our solution is that it can be used as treatment and vaccine. In infected people, the peptide will prevent viral entry and replication, while bolstering the immune response and formation of neutralising antibodies that can eliminate the virus. Other approaches may neutralise the virus, but many alternatives such as antibody therapies and viral-neutralising compounds will leave the body vulnerable to repeat infection. In those who haven’t been infected, the peptide will display critical immunoepitopes for antibody and T cell responses against the key parts of the virus necessary for forming a neutralising response. The peptide can also be used in conjunction with other treatments and vaccines—and may bolster the efficacy of spike protein vaccines in particular—although that shouldn’t be necessary if we achieve in vivo results suggested by the in silico modelling.”

Adam Hamdy, a medical consultant and author, who recently joined the company’s advisory board, says, “The microbiological characteristics of SARS-CoV-2 make it extremely unlikely that current vaccine approaches, which rely on training the immune system but present key challenges with this virus, will offer anything more than partial protection at best. It was clear to me that any effective response to this virus had to target it directly while also bolstering immune response.”

Importantly, Ligandal’s peptide has advantages over other technologies in development because it is room temperature stable, meaning it represents a genuinely global solution, both in terms of logistics and the storage of the medicine. It also has a low cost per dose once at mass production scale, which means global producton is entirely feasible. It can also move rapidly through preclinical and clinical studies given the accelerated global regulatory environment and simple at scale manufacturing process.

Andre Watson says, “As hostile actors take note of the havoc caused by the SARS-CoV-2 virus, it is clear we need better ways to ramp up our biodefense capabilities. A rapid four-year conventional vaccine cycle to trial a single solution isn’t going to be sufficient to meet future threats. Ligandal modelled its peptide within five hours of receiving a genetic sequence of the virus, and was ready to test its response in two months. We anticipate being ready to commence clinical studies later this year or very early next year. Our only limitation in getting this to the general public is how quickly we can move through the clinical studies.”

Adam Hamdy says, “A long term solution to the COVID-19 problem lies in genetic medicine. Ligandal’s peptide is an exciting leap forward in our ability to address and neutralise the virus directly. Unlike conventional vaccines, which only get one shot at proving efficacy, Ligandal’s peptide can be improved by rewriting its genetic code in response to novel viral variants, giving us the opportunity to rapidly iterate and keep at the problem until we get the answer absolutely right.”

About Ligandal

Based in San Francisco, Ligandal is a genetic medicine company that uses nanotechnology to develop targeted and personalised therapies.

For more information visit http://www.ligandal.com

Share article on social media or email:

Health

Brentwood Donates 14,000 Face Shields to Healthcare and Essential Workers

Leave a comment


Brentwood Donates 5,000 Face Shields to Penn State Health St. Joseph in Reading, PA

We wanted to protect those working to keep us safe and healthy, particularly in the communities where we live and operate.


READING, Pa. (PRWEB)

Brentwood is proudly partnering with numerous hospitals to supply critical personal protection equipment as the COVID-19 pandemic continues. In the last few weeks, Brentwood has donated 14,000 reusable face shields to protect healthcare and essential workers in the locales where it operates.

Five thousand face shields were donated to Penn State Health St. Joseph, in Reading, PA; 3,000 were given to the Lebanon VA Medical Center in Lebanon, PA; 3,000 went to the Martinsburg VA Medical Center in Martinsburg, WV; and 3,000 were provided to Wadley Regional Medical Center in Hope, AR, and Texarkana, TX.

Brentwood ensured that a company representative was on site to personally present the face shields to the above-mentioned organizations.

“We wanted to protect those working to keep us safe and healthy, particularly in the communities where we live and operate,” said Brentwood President, Peter Rye. “We reached out to many organizations to see where the greatest need was, and we were happy to jump in and help.”

When COVID-19 took hold in the U.S. several months ago, Brentwood assessed its capabilities and decided to develop the reusable face shield product.

“Our facilities were already equipped to form medical packaging and injection molded components,” said Walter Banta, Brentwood’s Senior Director of Operations, “so developing a face shield was an easy decision.”    

The face shield design and tooling were completed within weeks, enabling Brentwood to ramp up production in its Reading, PA, facilities. These include an ISO Class 7 cleanroom and a state-of-the-art injection molding facility.

In April, the company received official authorization from the U.S. Food & Drug Administration to supply its face shields specifically to healthcare workers fighting COVID-19. This approval falls within the Emergency Use Authorization (EUA) guidelines.

Brentwood’s face shields will also protect non-healthcare essential workers, tasked with keeping grocery stores, warehouses, and other critical processes operational during this difficult time. They are available for order here: https://www.brentwood-medical.com/face-shields/.

About Brentwood:

Brentwood Industries, Inc., is a family-owned, family-run business, operating in the U.S., India, Thailand, Mexico, and the Czech Republic. For over 50 years, Brentwood has applied plastic technologies to solve unique customer challenges and fostered a culture of innovation, entrepreneurship, and sustainability. Today, Brentwood is an industry leader in the development, engineering, and production of plastic solutions for cooling tower, medical, water treatment, transportation, stormwater management, construction, and battery applications.

In the medical sector, Brentwood is a leading manufacturer of custom thermoformed and injection molded solutions for device packaging, trays, components, and housings for imaging and diagnostic equipment. The company’s two state-of-the-art ISO Class 7 cleanrooms are equipped with the latest technologies and certified to ISO 9001 quality standards. With vast design knowledge, forming capabilities, and materials expertise, Brentwood produces functional and aesthetic parts that provide sustainable solutions for end-procedure efficiency.

Share article on social media or email:

Health

Sculpted Body – A Lagree Fitness Studio

Leave a comment


News Image

We have implemented a strict protocol to provide a safe environment for anyone coming into our studio. Temperature checks are done with a touchless thermometer as soon as anyone enters the studio.


MARIETTA, Ga. (PRWEB)

Sculpted Body, a Lagree Fitness studio located in East Cobb, GA, reopened May 11th after voluntarily closing on March 17th due to the Corona Virus Pandemic.

Kathy Dickson, Owner of Sculpted Body, expressed her confidence regarding the new procedures that have been put in place in order to keep instructors and clients safe. “We have implemented a strict protocol to provide a safe environment for anyone coming into our studio. Temperature checks are done with a touchless thermometer as soon as anyone enters the studio. Two of our Megaformers have been removed to allow for more social distancing. Now with only 6 machines in the studio, every piece of equipment is placed 6.5 feet apart. Additionally, we have flipped every other machine to face the opposite direction. This allows for 10.5 feet diagonally from front platform to front platform.”

The cleaning protocols at Sculpted Body are also very strict, with the use of CDC certified cleaning products. Machines are wiped down by clients after each class. Once the studio has been vacated, the instructor thoroughly wipes the machines and all handles down a second time before the next class. Door knobs, handles, and all common surfaces are wiped down after each class as well.

Class times have also been staggered to allow for extra cleaning time and to all but eliminate the chance of clients passing through the studio in between classes. “There are never more than 8 people in the studio at any given time,” says Dickson

Sculpted Body has also added new instructors to help balance the increase in members and clients that the company experienced before initially closing for the pandemic. These new fitness instructors are Angie Callahan and Victoria Bradley. With rotating schedules, clients interested in Angie’s classes can see her at the studio during the following class times:

  • Tuesdays at 7:30 AM and 9:30 AM

For clients interested in taking classes from Victoria, members can sign up for her classes on:

  • Thursdays at 5:15 PM and 6:15 PM

About Angie Callahan

Originally from Green Bay, Wisconsin, Angie is an ACE Certified Personal Trainer, and is also certified as a Les Mills GRIT coach. She has been teaching classes at Sculpted Body since November. Her positive attitude and encouraging teaching style work well to keep the energy levels up in her small group classes.

About Victoria Bradley

Victoria has been active her entire life, with experience in gymnastics, swimming, martial arts, and kickboxing. She is also a certified nutritionist and personal trainer. As an instructor she is an excellent motivator to her students, encouraging clients to challenge themselves during her workouts. For members who want to push their limits and achieve more from their fitness regime, Victoria is the perfect choice for a teacher.

About Sculpted Body

In business for 8 years, Sculpted Body is a certified Lagree Fitness studio offering classes on the Megaformer. A small boutique studio Sculpted Body has only 6 spaces per class allowing for personalized hands on instruction. These 50 minute full body classes are core based and high intensity but low impact. With modifications available to the exercises, all fitness levels are welcome. Sculpted Body’s small group sessions offer personalized assistance in a positive and encouraging environment. For those not comfortable in a group setting they also offer private sessions. To learn more about Sculpted Body, the Megaformer and Lagree Fitness visit: https://sculptedbodyatl.com/

Share article on social media or email:

Health

Mother Earth Juice Bar Launches New Smoothie called “Fight Back”

Leave a comment


Dr. Simone Lord

I’m on a mission to help people prosper and be in the best of health.”


QUEENS, N.Y. (PRWEB)

Mother Earth Juice Bar has a new, delicious smoothie called, “Fight Back”, which packs a delicious, nutritious, powerful punch. The new smoothie is high in anti-oxidants and offers many health benefits. Mother Earth has been in business for three years and has been making great juices and smoothies with enticing names such as the “Immune Power”, the “Take Care of Me”, “Man Man Power”, “Liver Tonic”, “Toxin Free”. “Energy Booster”, “Energy Elixir”, “Digestive Delight” , the “Power Shot” and more since 2017.

Dr. Simone Lord, a naturopathic doctor and pastor, started Mother Earth Juice Bar & Health Foods “to help people to attain better health, especially in communities of color.,” said Dr. Lord. They specialize in freshly pressed natural juices, tonics, elixirs, loose herbs, teas, herbal remedies and hot meals to help clients boost their health..

Mother Earth Juice Bar is helping people worldwide to restore optimum health and wellness by arming them with juice and smoothie recipes as well as herbal remedies. Dr. Lord’s patent pending Olive Leaf Tea Formula and Amazing Oil have clients coming back for more each day.

Dr. Simone Lord is the author of five books and has been on a mission to help people live their best, healthiest lives since 2006. She is a practicing pastor and naturopath with a church and wellness center in Jamaica Queens, called Inspire NY. Dr. Lord is currently ‘seeing’ clients via Facetime and utilizing technology to read their irises for the purpose of Iridology. She then makes recommendations based on the consultation and markings that she sees in their eyes, tongue, nails and skin.

Please visit http://www.motherearthjuice.com for more information on maintaining the best of health.

Share article on social media or email:

Health

Asthma Not Associated With Increased Risk of Hospitalization Among COVID-19 Patients

Leave a comment


AAAAI Logo

“More studies must be done to look at the underlying immune modulation caused by asthma or asthma treatment to see what impact it may have on COVID-19 outcomes.” – Anju T. Peters, MD, MSCI, FAAAAI


MILWAUKEE (PRWEB)

According to research from The Journal of Allergy and Clinical Immunology (JACI), patients with asthma were not more likely to be hospitalized due to COVID-19 than those without asthma. This finding comes despite asthmatics being more prevalent in the study’s cohort than would be expected given the estimates of asthma prevalence nationwide.

This study set out to examine the prevalence of asthma and comorbidities in asthmatics with COVID-19. In addition, researchers determined the risk of hospitalization due to COVID-19 in asthmatics and looked at inhaled corticosteroid use and risk of hospitalization due to COVID-19.

The retrospective study was conducted across 10 hospitals affiliated with Northwestern

Medicine via automated chart review using Northwestern Medicine’s Enterprise Data Warehouse, an electronic repository of health records. In total, 1,526 patients with COVID-19 were identified and used in the study. Of those, 220 (14.4%) had asthma, which is significantly higher than the national asthma prevalence rate of eight to nine percent. These numbers were in line with published U.S. data from the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report during the study period.

Two models were used to examine if asthma was a risk for hospitalization due to COVID-19. The first model adjusted for demographic data including age, gender, and ethnicity, while the second model also adjusted for multiple risk factors, including smoking and obesity. In both models, there was no significant difference in the risk of hospitalization between asthmatics and non-asthmatics.

The prevalence of many comorbidities including obesity, hypertension, sleep apnea, COPD, and gastroesophageal reflux disease was higher in patients with asthma and COVID-19 than in non-asthmatics with COVID-19. However, these comorbidities did not translate to a higher rate of hospitalization in asthmatics compared to non-asthmatics with COVID-19. Patients with asthma also had a higher prevalence of allergic rhinitis, rhinosinusitis, and immunodeficiencies. Interestingly, rhinosinusitis was associated with a lower risk of hospitalization.

Dramatic racial disparities have been reported during the COVID-19 pandemic and this was true in this study. Non-Hispanic African Americans and Hispanics or Latinos comprised a significant proportion of the asthma cohort with COVID-19 and had higher likelihood of COVID-19 related hospitalizations in general.

Chart review was completed to document which asthmatic patients with COVID-19 had a prescription of an inhaled corticosteroid (ICS), combination inhaled corticosteroid plus long-acting beta-agonist (ICS/LABA), and/or systemic corticosteroids. Only one patient was on a biologic. Just under half (48.2%) of the patients were prescribed the aforementioned medications, and in general the risk of hospitalization for these patients was not significantly greater than for those not on them.

There was also no observable difference in mortality rates between patients with COVID-19 who had asthma and those who did not. Laboratory assessment actually saw lower levels of biomarkers used to identify COVID-19 severity in patients with asthma, though additional studies must be performed to understand why this is and if asthmatics may have any protection against the virus.

“We would usually expect for asthmatic patients to have worse outcomes, as viral illness often can set off asthma exacerbations,” said Anju T. Peters, MD, MSCI, FAAAAI, corresponding author of the study. “More studies must be done to look at the underlying immune modulation caused by asthma or asthma treatment to see what impact it may have on COVID-19 outcomes.”

Another limitation of the study, according to Dr. Peters, was that they were not able to assess the contribution of asthma severity or asthma endotypes to COVID-19 disease severity and cautioned that healthcare workers need to be vigilant of older patients, those with certain comorbidities, African Americans, and Hispanics as they are at increased risk of hospitalization in general due to COVID-19.

You can learn more about asthma and COVID-19 on the American Academy of Allergy, Asthma & Immunology website, aaaai.org.

The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI’s Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.

Share article on social media or email:

Industry: Healthcare

Mount Sinai Health System Appoints Beth Oliver, DNP, RN, as Senior Vice President and Chief Nursing Executive

Leave a comment



NEW YORK (PRWEB)

Mount Sinai Health System has appointed Beth Oliver, DNP, RN, to the role of Senior Vice President and Chief Nursing Executive.

In this newly created role, Dr. Oliver will be responsible for the practice of nursing across the health system and will collaborate with the senior executive team as well as the chief nursing officers throughout Mount Sinai.

“As Chief Nursing Executive, her top three priorities will be ensuring the safety and quality of care for our patients, transforming the care we provide, and decreasing the overall costs of that care. These priorities, when well implemented, will improve patient experience,” said Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System. “In addition, Dr. Oliver will continue to develop and maintain Mount Sinai’s national reputation for excellence in nursing services. In collaboration with executive leadership and the Chief Nursing Officers, she will participate in the organization’s strategic plan—setting annual and long-term performance goals—and will leverage the Health System’s nursing excellence to advance the achievement of strategic goals, optimize clinical outcomes, enhance employee engagement, and promote a best-in-class patient experience.”

A nationally recognized cardiovascular leader, Dr. Oliver has fostered and supported evidence-based, patient-centered care throughout her career. For more than 28 years, Dr. Oliver has been a transformational cardiac nurse leader at Mount Sinai, most recently serving as Senior Vice President of Cardiac Services for the Health System, in which she leads cardiovascular service line strategy and operations for the Health System while also being responsible for ensuring the delivery of quality care to Mount Sinai Heart patients.

In addition to her Mount Sinai leadership roles, Dr. Oliver has led numerous cardiovascular health-related community outreach programs in partnership with the American Heart Association. In July 2018, Dr. Oliver was appointed President of the American Heart Association’s Board of Directors in New York City, becoming the first nurse to hold the position of Board President.

As a clinician, an executive, and a nurse, Dr. Oliver is committed to advancing population health and the current and future role of nurses in achieving this goal.

Dr. Oliver received her MS from Columbia University and her DNP from Case Western Reserve University.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

Health

Announcing RevSpring Arrived™ Parking Lot Waiting Room Application

Leave a comment


“RevSpring Arrived™ reduces the potential exposure to others with COVID-19 or other infectious diseases and gives providers more control over the flow of patients in their facilities at one time,” said RevSpring vice president of patient engagement Howard Bright.


LIVONIA, Mich. (PRWEB)

RevSpring, the leading provider of healthcare financial engagement and payment solutions, today announced a new pre-appointment, virtual waiting room application that enables contactless patient check-in, visit prep, and payment collection from their cell phone in their car. RevSpring Arrived™ connects patients and front office staff digitally, with easy-to-use check-in communications and co-payment processing to safely and efficiently welcome and prepare patients for their appointments.

“RevSpring is pleased to provide another swift innovation in response to the challenges facing healthcare providers as they accept patients and adhere to social distancing requirements,” said RevSpring CEO Scott MacKenzie. “Arrived helps solve the short-term challenges of minimizing waiting room contact in the wake of the highly infectious coronavirus. Clients will also appreciate the long-term impact of collecting co-payments without burdening already busy registrars.”

From parking lots to living rooms to their kids’ lacrosse games, the bottom line will be check-in-anywhere convenient for providers and their patients, along with safer in-person interactions for everyone.

Arrived (found at Arrived.care) is available as a stand-alone application for any provider in need of secure check-in communication—including online registration and customizable text messages. Optionally, Arrived integrates with RevSpring’s Talksoft® appointment reminder platform for a consistent and smooth patient communication process. Patients also will be digitally empowered to make payments from anywhere through the application prior to healthcare visits.

Front office staff using Arrived can monitor virtual patient check-ins using a specially designed dashboard. Patients benefit from using Arrived in a variety of settings including waiting for their appointments in a parking lot or having a contactless experience in a healthcare waiting room. Arrived can also be used to encourage patients to answer basic questions or review safety protocols prior to appointments.

Arrived is a flexible digital solution that provides peace of mind as it protects patients and providers. Using proven technologies for pre-service engagement and payment, it’s a natural extension to RevSpring’s comprehensive patient financial engagement platform and a crucial solution as more patients return for facility visits.

“Arrived reduces the potential exposure to others with COVID-19 or other infectious diseases and gives providers more control over the flow of patients in their facilities at one time,” said RevSpring vice president of patient engagement Howard Bright. “We expect that its functionality will continue evolving in response to client feedback, and as providers realize the financial benefits Arrived helps facilitate.”

About RevSpring

RevSpring leads the market in financial communications and payment solutions that inspire patients to participate in and pay for their healthcare. The company has built the industry’s most comprehensive and impactful suite of patient engagement, OmniChannel communications and payment solutions backed by behavior analysis, propensity-to-pay scoring, contextual messaging, and user experience best practices. Using proprietary data analytics to tailor the engagement from pre-service to post-service, we improve the financial experience and outcomes for providers and their patients. To learn more, visit revspringinc.com/healthcare.

Share article on social media or email:

Health

COVID-19 Clinical Trial of Immune Therapy Open at Mount Sinai, Made Possible by Philanthropic Donation

Leave a comment



NEW YORK (PRWEB)

Mount Sinai Health System is beginning the first clinical trial in the New York metropolitan region of an immune-boosting therapy in COVID-19 patients.

The Phase 2 randomized trial is expected to recruit 66 patients to study peginterferon lambda in hospitalized patients receiving supplemental oxygen. Peginterferon lambda is injected under the skin as a single, one-time dose, and scientists believe it can help the immune system control the virus infection, decreasing the duration and severity of COVID-19.

“There is significant evidence from laboratory studies done here at Mount Sinai and abroad that patients’ own immune systems are making inadequate amounts of interferon lambda—an alert signal the lungs normally send out to the immune system that a virus is present—when patients are infected with the coronavirus causing COVID-19,” said trial principal investigator Thomas Marron, MD, PhD, Assistant Director of Early Phase and Immunotherapy Clinical Trials at The Tisch Cancer Institute at Mount Sinai. “As naturally occurring interferon lambda is the first line of defense against COVID-19, we have designed a clinical trial that will quickly determine whether treatment with peginterferon lambda will decrease the severity of COVID-19.”

Scientists at Mount Sinai knew about peginterferon lambda from Phase 3 trials for viral hepatitis and felt its antiviral properties would be beneficial to COVID-19 patients based on studies in mouse models. Scott Friedman, MD, Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai, sought out the maker of the therapy, Eiger Biopharmaceuticals.

Together with Eiger, Dr. Friedman also sought funding from the COVID-19 Early Treatment Fund started by Silicon Valley entrepreneur and philanthropist Steve Kirsch, who in turn found matching funds from donors that include Corrigan Walla Foundation and David Baszucki, the founder and CEO of Roblox Corporation, and his wife, author Jan Ellison Baszucki. The total monetary donation was $500,000, and Eiger Biopharmaceuticals donated the drug for the trial.

“This collaboration between scientists and private industry is what can foster needed drug development for patients during this unprecedented pandemic,” Dr. Friedman said. “We’re hopeful about the prospects for peginterferon lambda based on its activity against SARS-CoV-2, the virus that leads to COVID-19, in cultured cells and animal models and because of its safety in thousands of patients who have received the drug for other conditions. This clinical trial will be important to determine if the drug has activity against COVID-19 in patients.”

Other sites are testing peginterferon lambda’s effectiveness prophylactically and in outpatients with mild COVID-19 cases. Mount Sinai’s Human Immune Monitoring Center, led by Miriam Merad, MD, PhD, Director of the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai, will perform extensive analysis of patients’ blood to characterize the response to the peginterferon lambda, and help determine if it is effective in activating the immune system to attack the coronavirus.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

Health

Inventive Sleep™ to Launch New Sleep Wellness Blog

Leave a comment


Promoting feel-good experiences has never been more important.


NAPERVILLE, Ill. (PRWEB)

Sleep Products Innovator Tracy Laskowski Miller will soon be sharing her sleep products and tips through her newly launched blog and website. Tracy has combined her background in material research and design to help consumers find the most functional sleep products that work for them. The blog will highlight the best features about her products, proven and emerging sleep technologies, as well as the secrets to a good night’s sleep, according to her and other leading experts.

“I am always inspired by all the stories people share with me on how a great night’s sleep plays a role in their lives,” says Tracy Laskowski Miller, Sleep Products Innovator and Founder of Inventive Sleep. “A favorite pillow, or blanket has uplifted people’s spirits for decades, helping them deal with the stresses of life and, I believe, inspiring them to share these feelings with their friends and family. Promoting feel-good experiences has never been more important, and this is at the heart of the Sleep Secrets and Inspirations content.”

The blog will be posting new articles and interviews several times a week, and new post announcements can be found on Inventive Sleep’s social media pages. The first few posts will feature cooling bedding products for the summer, an innovative new performance sheet from Pottery Barn Teen, and sleep recovery advice from a physical performance coach who has experience working with elite athletes including the Golden State Warriors and Chicago Bulls.

Tracy believes the sleep experience should be fun. She wants her audience to look forward to going to bed at night, and anticipate waking up in the morning feeling refreshed. Some bedding products are designed for functionality rather than fashion, and have the consumers’ well-being in mind at all times. The goal of Sleep Secrets and Inspirations is to help her audience find products they love in order to sleep better and feel better so that they can take on the world.

“Many people understand the benefits of getting a good night’s sleep,” says Tracy. “But there’s always questions on which products to buy, why, and how to use them. This makes people feel stressed, overwhelmed, and uncertain if they have purchased a product they will enjoy. We are demystifying the sleep experience with an informative and fun-filled conversation on how sleep helps people with everyday living. We will cover everything from health and wellness to beauty and construction, along with interviews with thought leaders to add some perspective.”

The blog is set to be launched Wednesday, June 10, 2020 and will be located at http://www.inventivesleep.com/blog.

To find out more information, visit http://www.inventivesleep.com or follow Inventive Sleep on Instagram at http://www.instagram.com/inventivesleep.

Share article on social media or email: